Literature DB >> 11950826

Ablative therapy for liver tumours.

E A Dick1, S D Taylor-Robinson, H C Thomas, W M W Gedroyc.   

Abstract

Established ablative therapies for the treatment of primary and secondary liver tumours, including percutaneous ethanol injection, cryotherapy, and radiofrequency ablation, are discussed. Newer techniques such as magnetic resonance imaging guided laser interstitial thermal therapy of liver tumours has produced a median survival rate of 40.8 months after treatment. The merits of this newly emerging technique are discussed, together with future developments, such as focused ultrasound therapy, which holds the promise of non-invasive thermoablation treatment on an outpatient basis.

Entities:  

Mesh：

Year:  2002        PMID： 11950826      PMCID： PMC1773197          DOI： 10.1136/gut.50.5.733

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  48 in total

1.  A clinical, noninvasive, MR imaging-monitored ultrasound surgery method.

Authors:  K Hynynen; W R Freund; H E Cline; A H Chung; R D Watkins; J P Vetro; F A Jolesz
Journal:  Radiographics       Date:  1996-01       Impact factor: 5.333

2.  MRI guidance of infra-red laser liver tumour ablations, utilising an open MRI configuration system: technique and early progress.

Authors:  M G de Jode; G M Lamb; H C Thomas; S D Taylor-Robinson; W M Gedroyc
Journal:  J Hepatol       Date:  1999-08       Impact factor: 25.083

3.  MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: demonstration of feasibility at 0.2 T.

Authors:  E M Merkle; D T Boll; T Boaz; J L Duerk; Y C Chung; G H Jacobs; M E Varnes; J S Lewin
Journal:  Magn Reson Med       Date:  1999-07       Impact factor: 4.668

Review 4.  Liver metastases: interventional therapeutic techniques and results, state of the art.

Authors:  T J Vogl; P K Müller; M G Mack; R Straub; K Engelmann; P Neuhaus
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 5.  Radiofrequency thermal ablation of liver tumors.

Authors:  H Rhim; G D Dodd
Journal:  J Clin Ultrasound       Date:  1999-06       Impact factor: 0.910

6.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

7.  Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.

Authors:  A J Bilchik; T F Wood; D Allegra; G J Tsioulias; M Chung; D M Rose; K P Ramming; D L Morton
Journal:  Arch Surg       Date:  2000-06

Review 8.  Interventional MR: interstitial therapy.

Authors:  T J Vogl; M G Mack; P K Müller; R Straub; K Engelmann; K Eichler
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

9.  Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience.

Authors:  G Francica; G Marone
Journal:  Eur J Ultrasound       Date:  1999-05

10.  Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.

Authors:  S N Goldberg; G S Gazelle; C C Compton; P R Mueller; K K Tanabe
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860
View more
  15 in total

Review 1.  Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?

Authors:  J Schölmerich; D Schacherer
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 2.  [Magnetic resonance tomography guided focussed ultrasound surgery (MRgFUS) in tumor therapy--a new noninvasive therapy option].

Authors:  S A Hengst; T Ehrenstein; H Herzog; A Beck; I Utz-Billing; M David; R Felix; J Ricke
Journal:  Radiologe       Date:  2004-04       Impact factor: 0.635

3.  MR imaging-guided interstitial photodynamic laser therapy for advanced head and neck tumors.

Authors:  H Rolf Jäger; Magali N Taylor; Tamer Theodossy; Colin Hopper
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

4.  Concepts and preliminary data toward the realization of image-guided liver surgery.

Authors:  David M Cash; Michael I Miga; Sean C Glasgow; Benoit M Dawant; Logan W Clements; Zhujiang Cao; Robert L Galloway; William C Chapman
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

5.  Experimental study on ultrasound-guided intratumoral injection of "Star-99" in treatment of hepatocellular carcinoma of nude mice.

Authors:  Li-Wu Lin; Xiao-Dong Lin; Yi-Mi He; Shang-Da Gao; En-Sheng Xue
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

6.  Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hypersplenism.

Authors:  Quan-Da Liu; Kuan-Sheng Ma; Zhen-Ping He; Jun Ding; Xue-Quan Huang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

7.  [Update on interstitial brachytherapy].

Authors:  T Bretschneider; N Peters; P Hass; J Ricke
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

8.  A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy.

Authors:  Gun Min Kim; Hei-Cheul Jeung; Dokyung Kim; Joo Hoon Kim; Sang Hyun Yoon; Eun Suk Jung; Sang Joon Shin
Journal:  Cancer Res Treat       Date:  2010-12-31       Impact factor: 4.679

Review 9.  Histotripsy methods in mechanical disintegration of tissue: towards clinical applications.

Authors:  Vera A Khokhlova; J Brian Fowlkes; William W Roberts; George R Schade; Zhen Xu; Tatiana D Khokhlova; Timothy L Hall; Adam D Maxwell; Yak-Nam Wang; Charles A Cain
Journal:  Int J Hyperthermia       Date:  2015-02-24       Impact factor: 3.914

10.  Outcome of combined hepatocellular and cholangiocarcinoma of the liver.

Authors:  Jue Wang; Fenwei Wang; Anne Kessinger
Journal:  J Oncol       Date:  2010-09-02       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.